A systematic review: the appraisal of the effects of metformin on lipoprotein modification and function
Summary Aims Metformin is a commonly prescribed anti‐hyperglycaemic pharmacological agent, and it remains a staple in the management of type II diabetes. In addition to metformin's glucose lowering effects, research has indicated that metformin inhibits glycation‐mediated and oxidative modifica...
Main Authors: | K. G. Kheniser, S. R. Kashyap, T. Kasumov |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-02-01
|
Series: | Obesity Science & Practice |
Subjects: | |
Online Access: | https://doi.org/10.1002/osp4.309 |
Similar Items
-
Effects of Metformin and diet on hemoglobin, cholesterol and triglyceride levels of Type 2 diabetic Patients
by: Rana Talib Almuswie, et al.
Published: (2019-04-01) -
Effects of Metformin and diet on hemoglobin, cholesterol and triglyceride levels of Type 2 diabetic Patients
by: Rana Talib Almuswie, et al.
Published: (2019-04-01) -
Effects of Metformin and diet on hemoglobin, cholesterol and triglyceride levels of Type 2 diabetic Patients
by: Rana Talib Almuswie, et al.
Published: (2019-04-01) -
Study of Blood Leptin Levels before and After Treatment with Metformin in Diabetes Type Ii Patients
by: R Didehdar, et al.
Published: (2005-04-01) -
Plasma lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with acute ischemic stroke
by: Holanda Maurus Marques de Almeida, et al.
Published: (2004-01-01)